Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKinsey
Argus Health
AstraZeneca
US Army
Harvard Business School
Colorcon
Healthtrust
Boehringer Ingelheim

Generated: July 21, 2018

DrugPatentWatch Database Preview

Iothalamate meglumine - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for iothalamate meglumine and what is the scope of iothalamate meglumine freedom to operate?

Iothalamate meglumine
is the generic ingredient in five branded drugs marketed by Liebel-flarsheim and Mallinckrodt, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for iothalamate meglumine. One supplier is listed for this compound.
Summary for iothalamate meglumine
Pharmacology for iothalamate meglumine
Medical Subject Heading (MeSH) Categories for iothalamate meglumine
Synonyms for iothalamate meglumine
1-Deoxy-1-(methylamino)-D-glucitol 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate
1-Deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophthalamate (salt)
13087-53-1
16240-57-6
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid,6-
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid; (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid; 6-(methylamino)hexane-1,2,3,4,5-pentol
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid;6-(methylamino)hexane-1,2,3,4,5-pentol
519-25-5
AC1L19JR
AC1LCVC4
AN-18407
Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:1)
CA003316
CHEBI:31714
CHEMBL1201125
Conray (TN)
Conray 280
Conray 30
Conray 43
Conray 60
Conray meglumin
Conray meglumine 282
Contrix 28
Cysto-Conray
D-Glucitol, 1-deoxy-1-(methylamino)-, 3-(acetylamino)-2,4,6-triiodo- 5-[(methylamino)carbonyl]benzoate (salt)
D-Glucitol, 1-deoxy-1-(methylamino)-, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate (salt)
D01999
DTXSID90199856
EINECS 235-998-9
Iotalamate de methylglucamine
Iotalamate de methylglucamine [French]
Iotalamic acid meglumine salt
Iothalamate meglumine (USP)
Iothalamate Meglumine [USAN]
Iothalamate meglumine [USP]
IOTHALAMATE MEGLUMINE; MEGLUMINE
Iothalamate methylglucamine
Iothalamate methylglucamine salt
Iothalamic acid N-methylgucamine salt
Isophthalamic acid, 5-acetamido-2,4,6-triiodo-N-methyl-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:1)
Jotalamsaeure methylglucaminesalz
Jotalamsaeure methylglucaminesalz [German]
LS-85183
Meglumine conray
Meglumine iotalamate
Meglumine Iotalamate Injection
Meglumine iotalamate injection (JP17)
Meglumine iothalamate
Meglumine Iothalamate (BAN)
Meglumine Iothalamate [BAN]
Meglumine isothalamate
Methylglucamine iotalamate
Methylglucamine iothalamate
SCHEMBL180546
UNII-XUW72GOP7W
XUW72GOP7W

US Patents and Regulatory Information for iothalamate meglumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Liebel-flarsheim CONRAY 30 iothalamate meglumine INJECTABLE;INJECTION 016983-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Liebel-flarsheim CONRAY iothalamate meglumine INJECTABLE;INJECTION 013295-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinckrodt VASCORAY iothalamate meglumine; iothalamate sodium INJECTABLE;INJECTION 016783-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Liebel-flarsheim CONRAY 43 iothalamate meglumine INJECTABLE;INJECTION 013295-002 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Farmers Insurance
Cantor Fitzgerald
Harvard Business School
US Department of Justice
Teva
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.